Ali Hassan Zeaiter
Ali Hassan Zeaiter publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Research Studies, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.
- World rank
- #1,126,627 of 7,710,434 ranked researchers
- Rank in Spain
- #22,761 of 204,306
- Works
- 98
- Citations
- 6.5k
- Citations per work
- 66.4
What does Ali Hassan Zeaiter research?
Ali Hassan Zeaiter's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (10%), Materials Science (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7273.8%
- Medicine7273.8%
- Everything else1313.7%
- Life Sciences1010.4%
- Physical Sciences22.1%
- Materials Science22.1%
- 1Oncology37% of their works
- 2Pulmonary and Respiratory Medicine34% of their works
- 3Molecular Biology7% of their works
- 4Cancer Research3% of their works
- 5Epidemiology3% of their works
- 6Biomaterials2% of their works
Research topics
Which keywords describe Ali Hassan Zeaiter's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.
- Neuroendocrine Tumors
- Cancer Genomics
- Chemotherapy-Induced Peripheral Neuropathy
- Cetuximab
- DNA
- CT Screening
- Genomic Profiles
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- Small-Cell Lung Cancer
- Lung Cancer
- Topoisomerases
- KRAS Mutations
- Taxanes
- Mutational Signatures
- Pancreatic Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Targeted Therapy1323 topics
- Clinical Trials1242 topics
- Chemotherapy1074 topics
- ALK Inhibitors621 topic
- EGFR Mutations621 topic
- Genomic Profiles621 topic
- Small-Cell Lung Cancer621 topic
- CT Screening211 topic
- Lung Cancer211 topic
- DNA141 topic
- Topoisomerases141 topic
- Cetuximab101 topic
- KRAS Mutations101 topic
- Chemotherapy-Induced Peripheral Neuropathy91 topic
- Taxanes91 topic
- Cancer Genomics81 topic
- Mutational Signatures81 topic
- Neuroendocrine Tumors81 topic
- Pancreatic Neuroendocrine Tumors81 topic
Where does Ali Hassan Zeaiter work?
Ali Hassan Zeaiter's main affiliation in the publication record is PharmaMar (Spain), Spain.
How many publications and citations does Ali Hassan Zeaiter have?
OpenAlex counts 98 works and 6,506 citations for Ali Hassan Zeaiter, an h-index of 25, ranking #1,126,627 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ali Hassan Zeaiter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.